Literature DB >> 16557295

Genetic epidemiology of intracerebral hemorrhage.

Daniel Woo1, Padmini Sekar, Ranajit Chakraborty, Mary A Haverbusch, Matthew L Flaherty, Brett M Kissela, Dawn Kleindorfer, Alexander Schneider, Jane Khoury, Laura R Sauerbeck, Ranjan Deka, Joseph P Broderick.   

Abstract

We have previously reported that family history of intracerebral hemorrhage (ICH) was associated with both lobar and nonlobar ICH. We sought to further examine this finding by analyzing differences by age and by apolipoprotein E (Apo E) genotype. All cases of hemorrhagic stroke in the greater Cincinnati area were identified through retrospective screening, and a subset was invited to undergo a direct interview and genetic testing. Interviewed subjects were matched to 2 controls by age, race, and sex. Conditional stepwise logistic regression modeling was used to determine whether having a first-degree relative with an ICH (FHICH) was an independent risk factor for ICH. Between May 1997 and December 2002, we recruited 333 cases of ICH. FHICH was found to be an independent risk factor for both lobar ICH (odds ratio [OR] = 3.9; P = .04) and nonlobar ICH (OR ratio = 5.4; P = .01) after controlling for the presence of numerous variables. Among nonlobar ICH cases, the risk appeared to be predominately in those age < 70 years. The presence of Apo E4 was associated with lobar ICH at age >/= 70 years but not at age < 70 years. Family history of ICH appears to be a significant risk factor for nonlobar ICH at age < 70 years. The presence of Apo E4 appears to be a risk factor for lobar ICH at age >/= 70 years but not at age < 70 years. Family history of ICH is a risk factor for lobar ICH after controlling for the presence of Apo E4.

Entities:  

Year:  2005        PMID: 16557295      PMCID: PMC1615714          DOI: 10.1016/j.jstrokecerebrovasdis.2005.08.002

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  10 in total

1.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.

Authors:  Daniel E Singer; Robert A Hughes; Daryl R Gress; Mary A Sheehan; Lynn B Oertel; Sue Ward Maraventano; Dyan Ryan Blewett; Bernard Rosner; J Philip Kistler
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

2.  Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy.

Authors:  S M Greenberg; M E Briggs; B T Hyman; G J Kokoris; C Takis; D S Kanter; C S Kase; M S Pessin
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

3.  Familial clustering of intracerebral hemorrhage: a prospective study in North Carolina.

Authors:  M J Alberts; M O McCarron; K L Hoffmann; C Graffagnino
Journal:  Neuroepidemiology       Date:  2002 Jan-Feb       Impact factor: 3.282

4.  Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study.

Authors:  Daniel Woo; Laura R Sauerbeck; Brett M Kissela; Jane C Khoury; Jerzy P Szaflarski; James Gebel; Rakesh Shukla; Arthur M Pancioli; Edward C Jauch; Anil G Menon; Ranjan Deka; Janice A Carrozzella; Charles J Moomaw; Robert N Fontaine; Joseph P Broderick
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

5.  Subarachnoid hemorrhage: a preventable disease with a heritable component.

Authors:  Brett M Kissela; Laura Sauerbeck; Daniel Woo; Jane Khoury; Janice Carrozzella; Arthur Pancioli; Edward Jauch; Charles J Moomaw; Rakesh Shukla; James Gebel; Robert Fontaine; Joseph Broderick
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

6.  Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

Authors:  J Rosand; E M Hylek; H C O'Donnell; S M Greenberg
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

7.  Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study.

Authors:  Daniel Woo; Brett M Kissela; Jane C Khoury; Laura R Sauerbeck; Mary A Haverbusch; Jerzy P Szaflarski; James M Gebel; Arthur M Pancioli; Edward C Jauch; Alexander Schneider; Dawn Kleindorfer; Joseph P Broderick
Journal:  Stroke       Date:  2004-04-15       Impact factor: 7.914

8.  Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.

Authors:  G W Rebeck; J S Reiter; D K Strickland; B T Hyman
Journal:  Neuron       Date:  1993-10       Impact factor: 17.173

9.  A molecular genetic study of intracerebral hemorrhage.

Authors:  C Graffagnino; M H Herbstreith; A D Roses; M J Alberts
Journal:  Arch Neurol       Date:  1994-10

10.  Effect of untreated hypertension on hemorrhagic stroke.

Authors:  Daniel Woo; Mary Haverbusch; Padmini Sekar; Brett Kissela; Jane Khoury; Alexander Schneider; Dawn Kleindorfer; Jerzy Szaflarski; Arthur Pancioli; Edward Jauch; Charles Moomaw; Laura Sauerbeck; James Gebel; Joseph Broderick
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

  10 in total
  3 in total

1.  Body mass index and etiology of intracerebral hemorrhage.

Authors:  Alessandro Biffi; Lynelle Cortellini; Caryn M Nearnberg; Alison M Ayres; Kristin Schwab; Aaron J Gilson; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; Jonathan Rosand
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

2.  Smoking and family history and risk of aneurysmal subarachnoid hemorrhage.

Authors:  D Woo; J Khoury; M M Haverbusch; P Sekar; M L Flaherty; D O Kleindorfer; B M Kissela; C J Moomaw; R Deka; J P Broderick
Journal:  Neurology       Date:  2009-01-06       Impact factor: 9.910

3.  Identification of nine genes as novel susceptibility loci for early-onset ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage.

Authors:  Yoshiji Yamada; Kimihiko Kato; Mitsutoshi Oguri; Hideki Horibe; Tetsuo Fujimaki; Yoshiki Yasukochi; Ichiro Takeuchi; Jun Sakuma
Journal:  Biomed Rep       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.